These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31005184)
1. The prognostic significance of intratumoral heterogeneity of 18F-FDG uptake in patients with oral cavity squamous cell carcinoma. Kimura M; Kato I; Ishibashi K; Shibata A; Nishiwaki S; Fukumura M; Sone Y; Nagao T; Umemura M Eur J Radiol; 2019 May; 114():99-104. PubMed ID: 31005184 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer. Kwon SH; Yoon JK; An YS; Shin YS; Kim CH; Lee DH; Jo KS; Lee SJ J Surg Oncol; 2014 Nov; 110(6):702-6. PubMed ID: 24975131 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related]
5. Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma. Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Salama AR; Truong MT; Sakai O Eur Radiol; 2020 Nov; 30(11):6322-6330. PubMed ID: 32524219 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
7. Use of Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718 [No Abstract] [Full Text] [Related]
8. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135 [TBL] [Abstract][Full Text] [Related]
9. Intra-tumor metabolic heterogeneity of gastric cancer on Liu G; Yin H; Cheng X; Wang Y; Hu Y; Liu T; Shi H Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779 [TBL] [Abstract][Full Text] [Related]
10. Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer. Liu S; Feng Z; Jiang Z; Wen H; Xu J; Pan H; Deng Y; Zhang L; Ju X; Chen X; Wu X Nucl Med Commun; 2018 Oct; 39(10):928-935. PubMed ID: 29771717 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. Son SH; Kim DH; Hong CM; Kim CY; Jeong SY; Lee SW; Lee J; Ahn BC BMC Cancer; 2014 Aug; 14():585. PubMed ID: 25112709 [TBL] [Abstract][Full Text] [Related]
12. Hypoxic volume evaluated by Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392 [TBL] [Abstract][Full Text] [Related]
16. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [TBL] [Abstract][Full Text] [Related]
18. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma. Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774 [TBL] [Abstract][Full Text] [Related]